Tenaya Therapeutics Appoints Eric Hyllengren As CFO
(RTTNews) - Tenaya Therapeutics, Inc. (TNYA), a clinical-stage biotechnology company, said on Monday that it has appointed Eric Hyllengren as Chief Financial Officer with effect from July 13.
Hyllengren most recently served as CFO of Zura Bio. Prior to Zura Bio, he served as CFO and Chief Operating Officer of Atara Biotherapeutics.
Earlier, he held roles of increasing responsibility across finance, investor relations, and business development over the course of 15 years at Amgen.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.